We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
(+11%)
Cap. Flow
-$707M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$99.9M |
| 2 |
Uber
UBER
|
+$71M |
| 3 |
Broadcom
AVGO
|
+$36.2M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$32.6M |
| 5 |
lululemon athletica
LULU
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$139M |
| 2 |
Apple
AAPL
|
+$72.7M |
| 3 |
VMW
VMware, Inc
VMW
|
+$47.1M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$42.3M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$35.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.73% |
| 2 | Financials | 13% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Prudential
PUK
$35.2B
| $260K | ﹤0.01% |
11,569
-158
| -1% | -$3.46K |
|
2902
CorMedix
CRMD
$584M
| $259K | ﹤0.01% |
68,882
+12,186
| +21% | +$41.9K |
|
|
NHY
2903
DELISTED
NORSK HYDRO A. S. ADR
NHY
| $259K | ﹤0.01% |
38,743
+313
| +0.8% | +$2.09K |
|
|
ASAI
2904
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
| $258K | ﹤0.01% |
18,688
-3,815
| -17% | -$47.6K |
|
|
NTCO
2905
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
| $258K | ﹤0.01% |
37,758
+1,619
| +4% | +$9.73K |
|
2906
Wheaton Precious Metals
WPM
$60.9B
| $258K | ﹤0.01% |
5,231
-20
| -0.4% | -$905 |
|
2907
Rimini Street
RMNI
$471M
| $258K | ﹤0.01% |
78,883
+11,026
| +16% | +$30.3K |
|
2908
American Coastal Insurance
ACIC
$493M
| $257K | ﹤0.01% |
27,217
+3,943
| +17% | +$31.7K |
|
2909
CS Disco
LAW
$279M
| $257K | ﹤0.01% |
33,857
-354
| -1% | -$2.23K |
|
2910
Blink Charging
BLNK
$87.9M
| $257K | ﹤0.01% |
75,802
+1,779
| +2% | +$5.55K |
|
|
INZY
2911
DELISTED
Inozyme Pharma
INZY
| $257K | ﹤0.01% |
60,294
+14,365
| +31% | +$51K |
|
2912
Ovid Therapeutics
OVID
$491M
| $257K | ﹤0.01% |
79,666
-3,125
| -4% | -$10.7K |
|
2913
Monte Rosa Therapeutics
GLUE
$1.35B
| $256K | ﹤0.01% |
45,360
-243
| -0.5% | -$953 |
|
2914
ArcelorMittal
MT
$55.3B
| $256K | ﹤0.01% |
9,023
+480
| +6% | +$11.7K |
|
|
TDK
2915
DELISTED
TDK CORP AMER DEP SH
TDK
| $256K | ﹤0.01% |
5,411
+61
| +1% | +$2.89K |
|
2916
Nerdy
NRDY
$96.7M
| $256K | ﹤0.01% |
74,581
-236
| -0.3% | -$724 |
|
2917
Tilly's
TLYS
$128M
| $256K | ﹤0.01% |
33,892
-194
| -0.6% | -$1.56K |
|
2918
Granite Ridge Resources
GRNT
$644M
| $254K | ﹤0.01% |
42,223
+13,274
| +46% | +$81.1K |
|
2919
Future Fuel
FF
$223M
| $253K | ﹤0.01% |
41,686
-461
| -1% | -$2.94K |
|
2920
Information Services Group
III
$251M
| $253K | ﹤0.01% |
53,619
-277
| -0.5% | -$1.21K |
|
|
GRTS
2921
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $252K | ﹤0.01% |
123,676
-545
| -0.4% | -$995 |
|
2922
Acacia Research
ACTG
$470M
| $251K | ﹤0.01% |
64,158
-420
| -0.7% | -$1.55K |
|
2923
Vivid Seats
SEAT
$85.4M
| $251K | ﹤0.01% |
1,985
+8
| +0.4% | +$1.09K |
|
2924
Erasca
ERAS
$6.39B
| $250K | ﹤0.01% |
117,606
-2,645
| -2% | -$5.58K |
|
2925
Timberland Bancorp
TSBK
$351M
| $250K | ﹤0.01% |
7,947
-306
| -4% | -$8.95K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2023 Portfolio in Review
As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
- RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
- RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
- RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.